Messenger RNA (mRNA) vaccines have reshaped the global biomedical landscape in recent years, demonstrating remarkable speed and flexibility in combating emerging infectious threats. While the first breakthroughs emerged in human health, veterinary medicine is rapidly becoming the next frontier where this technology could transform disease prevention, animal welfare and food security. The adoption of mRNA-based platforms for veterinary applications has the potential to redefine how vaccines are developed, manufactured and delivered.

Why Veterinary Medicine is Poised for Transformation

Veterinary medicine faces unique challenges. Animals live in diverse environments, often in large herds or flocks where disease outbreaks spread quickly. Traditional vaccines, though effective, can take years to develop and may not always adapt to the fast-evolving nature of pathogens. The mRNA vaccines offer a fundamentally different paradigm: they can be designed rapidly once the genetic sequence of a pathogen is known and their production can be standardised across multiple diseases using the same manufacturing platform